Calamos Advisors LLC bought a new stake in Endava plc (NYSE:DAVA – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 24,596 shares of the company’s stock, valued at approximately $1,915,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Tower Research Capital LLC TRC increased its stake in Endava by 433.3% in the third quarter. Tower Research Capital LLC TRC now owns 480 shares of the company’s stock valued at $39,000 after purchasing an additional 390 shares during the period. Signaturefd LLC increased its position in Endava by 194.9% in the 3rd quarter. Signaturefd LLC now owns 1,153 shares of the company’s stock valued at $66,000 after acquiring an additional 762 shares during the period. Global Retirement Partners LLC raised its stake in Endava by 41.8% during the 3rd quarter. Global Retirement Partners LLC now owns 1,234 shares of the company’s stock valued at $69,000 after acquiring an additional 364 shares during the last quarter. Financial Management Professionals Inc. acquired a new stake in Endava during the 4th quarter worth approximately $81,000. Finally, Quantbot Technologies LP acquired a new stake in Endava during the 1st quarter worth approximately $88,000. Hedge funds and other institutional investors own 62.23% of the company’s stock.
Endava Stock Down 1.4 %
Shares of NYSE DAVA opened at $29.92 on Monday. The stock has a market capitalization of $1.73 billion, a price-to-earnings ratio of 20.63 and a beta of 1.10. Endava plc has a 52 week low of $29.54 and a 52 week high of $81.06. The firm has a 50-day moving average price of $43.68 and a 200 day moving average price of $58.37.
Wall Street Analyst Weigh In
DAVA has been the topic of a number of recent research reports. TD Cowen dropped their target price on Endava from $85.00 to $52.00 and set an “outperform” rating on the stock in a report on Friday, March 1st. Needham & Company LLC cut their price objective on shares of Endava from $70.00 to $50.00 and set a “buy” rating for the company in a research report on Friday, March 1st. HSBC cut shares of Endava from a “buy” rating to a “hold” rating and raised their target price for the stock from $68.00 to $80.00 in a research note on Monday, January 8th. JPMorgan Chase & Co. upgraded shares of Endava from a “neutral” rating to an “overweight” rating and set a $49.00 price target on the stock in a research note on Tuesday, March 19th. Finally, Morgan Stanley downgraded shares of Endava from an “overweight” rating to an “equal weight” rating and raised their price objective for the company from $68.00 to $80.00 in a research report on Wednesday, January 24th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Endava has an average rating of “Moderate Buy” and a consensus target price of $60.78.
Read Our Latest Research Report on DAVA
About Endava
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
See Also
- Five stocks we like better than Endava
- 3 REITs to Buy and Hold for the Long Term
- Intuitive Surgical Leads the Robotic Surgery Movement
- What is the Dow Jones Industrial Average (DJIA)?
- Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
- What are earnings reports?
- MarketBeat Week in Review – 4/15 – 4/19
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.